Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1649]

Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone...

Dr Hope Rugo - University of California San Francisco, San Francisco, USA

Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone receptor HR+/HER2‐ advanced breast cancer patients ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )

Ramucirumab plus pembrolizumab improves OS in advanced NSCLC

Dr Roy Herbst - Yale Cancer Center, New Haven, USA

Ramucirumab plus pembrolizumab improves OS in advanced NSCLC ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )

War in Ukraine: Impacts on the Polish cancer care system and vaccination...

Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland

War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges ( Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland )

Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients

Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain

Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )

Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma...

Dr Iván Márquez-Rodas - Hospital General Universitario Gregorio Marañón, Madrid...

$Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy ( Dr Iván Márquez-Rodas - Hospital General Universitario Gregorio Marañón, Madrid, Spain )$

Recurrent non-invasive breast tumours may not always be related to the primary...

Dr Tanjina Kader - University of Melbourne, Melbourne, Australia

Recurrent non-invasive breast tumours may not always be related to the primary lesion ( Dr Tanjina Kader - University of Melbourne, Melbourne, Australia )

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )

EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari

EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )

Minimal residual disease in multiple myeloma

Prof Ola Landgren - University of Miami, Miami, USA

Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )

Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer...

Dr Diana Artene - American Society for Nutrition, Bucharest, Romania

Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients ( Dr Diana Artene - American Society for Nutrition, Bucharest, Romania )

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Update on the new EUSOMA quality indicators for breast cancer

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )

More from ecancer